Search results
Found 1361 matches for
An internationally recognised centre of excellence for biomedical and clinical research and teaching
Living reviews launched by Oxford and Cardiff in the wake of COVID-19 research
Coronavirus COVID-19 General Research
18 December 2020
In a combined effort to help COVID-19 researchers the University of Oxford and Cardiff University have launched a series of “living reviews” in Oxford University Press’s new open access journal “Oxford Open Immunology”.
Oxford University awarded £2.4 million to fund DPhil research in inflammation, immunology and musculoskeletal disease
Awards and Appointments General
18 December 2020
Oxford University has been awarded a £2.4 million grant, as part of the Kennedy Trust MB PhD scheme, to fund undergraduate medical students to undertake DPhil research in the areas of inflammation, immunology and musculoskeletal disease.
Oxford academics team up with charity to help disadvantaged babies & toddlers
Coronavirus COVID-19 General
17 December 2020
Developmental psychologists at University of Oxford and Oxford Brookes University have raised enough money to provide outdoor baby and toddler weather gear for 70 local families. The rain-sets, provided at discount by Wet Wednesdays, have been distributed by volunteers from Home-Start Oxford to disadvantaged families struggling this winter.
Professor Sir Rory Collins awarded the MRC Millennium Medal 2020
Awards and Appointments General
17 December 2020
Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.
Launch of new Scan Academy webinars
General Research
16 December 2020
Nuffield Department of Women's and Reproductive Health celebrate the successful launch of scan.academy - an initiative dedicated to improving obstetric ultrasound through state-of-the-art education.
Plastic surgeons recommend a review of cancer excision guidelines after finding variations in effectiveness
General Research
15 December 2020
A systematic review finds incomplete excision rates for basal cell carcinoma range from 4.7% to 20.4%, against recommended guidelines of 5%.
COVID-19 vaccine hesitancy in the UK
Coronavirus COVID-19 General
14 December 2020
The pandemic is testing our societal structures like never before. To deal with it successfully, we need to think and act collectively, led by our key institutions. But at a time when unity is critical, are we about to see the effects of a long-standing and corrosive drip feed of mistrust?
Cochrane ENT awarded NIHR funding for COVID-19 project
Coronavirus COVID-19 General Research
11 December 2020
Cochrane ENT at the Nuffield Department of Surgical Sciences has been awarded funding by the National Institute for Health Research (NIHR) to complete a suite of living systematic reviews investigating the effectiveness and safety of interventions to prevent and treat loss of smell after COVID-19 infection.
National COVID-19 Infections Survey reveals changes to pandemic over time
Coronavirus COVID-19 General Research
11 December 2020
Data from the National COVID-19 Infection Survey, done in partnership between the University of Oxford, the Office of National Statistics, Public Health England, University of Manchester and the Wellcome Trust, has revealed detailed characteristics of England’s coronavirus pandemic, including which factors have contributed most to case numbers over different phases and the prevalence of asymptomatic infections.
Key step for hepatitis research as patient database created
General Research
11 December 2020
For the first time, a comprehensive database comprising an initial cohort of more than 1,300 patients with chronic hepatitis B or hepatitis C infections has been developed for potential future research into the conditions.
University spinout PepGen awarded major financing to target Duchenne muscular dystrophy
Awards and Appointments General Innovation
9 December 2020
PepGen, a therapeutics company targeting severe neuromuscular diseases, including Duchenne muscular dystrophy (DMD), has closed a $45 million Series A funding round led by RA Capital Management with participation from Oxford Sciences Innovation (OSI), the company’s original seed investor.
£3M invested to drive forward early translation through five new Oxford-Bristol Myers Squibb Fellowships
Awards and Appointments General Innovation
9 December 2020
Five new Oxford-Bristol Myers Squibb Fellowships representing an investment of £3M have been announced today*. The fellowships (formerly Oxford-Celgene) will support postdoctoral researchers and clinicians across five departments within the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division, providing an opportunity for them to gain exposure to the field of commercial drug discovery and development.
University of Oxford awarded major European Research Council funding
Awards and Appointments General Research
9 December 2020
European Research Council grants worth more than €16.3 million have today been awarded to eight University of Oxford researchers for a range of cutting-edge projects.
First peer-reviewed results of phase 3 human trials of Oxford coronavirus vaccine demonstrate efficacy
Clinical Trials Coronavirus COVID-19 General Research
8 December 2020
Today University of Oxford and AstraZeneca researchers present a pooled analysis of Phase 3 trials of a vaccine against SARS-CoV-2 across two different dose regimens, resulting in an average efficacy of 70.4%.
Philharmonic Orchestra film special tribute concert for the Oxford vaccine team
Coronavirus COVID-19 General
7 December 2020
A special concert to say thank you and pay tribute to the achievements of the Oxford vaccine team has been recorded at the Sheldonian Theatre for a film screening in time for Christmas.
$10 million gift for new Nanoscience Institute in Oxford
General
3 December 2020
A new institute for nanoscience research is to open in Oxford thanks to a $10 million gift from The Kavli Foundation.
Hidden damage to lungs from COVID-19 revealed in new research study from University of Oxford & Sheffield
Coronavirus COVID-19 General Research
2 December 2020
Early findings from a study into longer-term damage amongst patients recovering from COVID-19 suggest that the use of cutting-edge scanning techniques may detect previously unseen lung damage.
SCALOP team discover new pancreatic cancer biomarker
General Research
30 November 2020
The discovery of pancreatic cancer biomarkers (naturally occurring molecules, genes or characteristics which can be used to confirm the presence or predict the outcome of a cancer) is vital in understanding patient outcomes and finding new therapeutic targets.
A clue to how a memory-enhancing pill might work
General Research
27 November 2020
Hundreds of dietary supplements have been reported to improve cognitive and emotional function in humans, but few have scientific foundation. A new study from the Department of Physiology, Anatomy & Genetics (DPAG) provides fresh insight into how dietary magnesium supplementation can influence memory performance.
Inhaled corticosteroids to be investigated as a possible treatment for Covid-19 in national PRINCIPLE Trial
Coronavirus COVID-19 General Research
27 November 2020
In Covid-19, inhaled budesonide may prevent damaging inflammation, stop the virus from getting into lung cells and inhibit viral replication.